BioCentury | Oct 4, 2010
Company News

Tigris Pharmaceuticals board of directors update

...Tigris Pharmaceuticals Inc. , Bonita Springs, Fla. Business: Cancer Appointed: Neil Flanzraich, chairman of ParinGenix Inc....
BioCentury | Jul 6, 2009
Company News

Ligand, ParinGenix deal

...eligible for royalties in other countries. Ligand has a right to terminate the deal if ParinGenix...
...does not complete the first commercial sale of a product within an undisclosed time period. ParinGenix's...
...ODSH in Phase IIb testing to treat COPD. Ligand Pharmaceuticals Inc. (NASDAQ:LGND), San Diego, Calif. ParinGenix Inc....
BioCentury | Aug 1, 2005
Company News

ParinGenix management update

ParinGenix Inc. , Tucson, Ariz. Business: Cardiovascular Hired: Eric Leire as CEO, formerly president and CEO at APT Therapeutics Inc. WIR Staff Cardiovascular...
BioCentury | Feb 14, 2005
Clinical News

PGX-100: Start Phase I

...ParinGenix will begin this month a placebo-controlled, dose-escalation, U.S. Phase I trial. ParinGenix Inc. , Tucson, Ariz...
Items per page:
1 - 4 of 4
BioCentury | Oct 4, 2010
Company News

Tigris Pharmaceuticals board of directors update

...Tigris Pharmaceuticals Inc. , Bonita Springs, Fla. Business: Cancer Appointed: Neil Flanzraich, chairman of ParinGenix Inc....
BioCentury | Jul 6, 2009
Company News

Ligand, ParinGenix deal

...eligible for royalties in other countries. Ligand has a right to terminate the deal if ParinGenix...
...does not complete the first commercial sale of a product within an undisclosed time period. ParinGenix's...
...ODSH in Phase IIb testing to treat COPD. Ligand Pharmaceuticals Inc. (NASDAQ:LGND), San Diego, Calif. ParinGenix Inc....
BioCentury | Aug 1, 2005
Company News

ParinGenix management update

ParinGenix Inc. , Tucson, Ariz. Business: Cardiovascular Hired: Eric Leire as CEO, formerly president and CEO at APT Therapeutics Inc. WIR Staff Cardiovascular...
BioCentury | Feb 14, 2005
Clinical News

PGX-100: Start Phase I

...ParinGenix will begin this month a placebo-controlled, dose-escalation, U.S. Phase I trial. ParinGenix Inc. , Tucson, Ariz...
Items per page:
1 - 4 of 4